Jiang Zhong Pharmaceutical Co.,Ltd (SHA: 600750)
21.17
-0.04 (-0.19%)
Sep 6, 2024, 3:00 PM CST
Jiang Zhong Pharmaceutical Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 747.25 | 708.29 | 598.24 | 505.69 | 473.74 | 463.6 | Upgrade
|
Depreciation & Amortization | 122.86 | 118.6 | 122 | 115.44 | 112.77 | 112.97 | Upgrade
|
Other Amortization | 4.13 | 3.69 | 0.45 | 0.3 | 0.28 | 0.26 | Upgrade
|
Loss (Gain) From Sale of Assets | -1.28 | -1.22 | 0.13 | -0.9 | 0.21 | 0.98 | Upgrade
|
Asset Writedown & Restructuring Costs | 2.53 | 2.01 | - | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | 57.69 | 40.05 | -61.47 | -51.25 | 15.98 | -22.4 | Upgrade
|
Provision & Write-off of Bad Debts | 0.27 | -1.7 | 1.34 | -0.31 | 1.65 | -2.71 | Upgrade
|
Other Operating Activities | -8.32 | 8.89 | 34.65 | 16.69 | 16.35 | 10.83 | Upgrade
|
Change in Accounts Receivable | -443.14 | 291.45 | 9.75 | 159.5 | 240.6 | 42.56 | Upgrade
|
Change in Inventory | -38.15 | -28.12 | -3.3 | -23.63 | -6.54 | 1.9 | Upgrade
|
Change in Accounts Payable | 534.61 | -101.84 | 309.96 | 200.5 | -92.82 | 33.69 | Upgrade
|
Change in Other Net Operating Assets | 5.56 | 8.94 | 10.66 | 1.19 | - | - | Upgrade
|
Operating Cash Flow | 971.08 | 1,036 | 1,022 | 917.04 | 752.5 | 641.18 | Upgrade
|
Operating Cash Flow Growth | -10.38% | 1.39% | 11.42% | 21.87% | 17.36% | 31.86% | Upgrade
|
Capital Expenditures | -203.01 | -208.88 | -345.73 | -188.49 | -182.53 | -76.33 | Upgrade
|
Sale of Property, Plant & Equipment | 0.35 | 0.25 | 0.05 | 1.24 | 0.66 | 0.08 | Upgrade
|
Cash Acquisitions | - | - | - | 197.89 | - | - | Upgrade
|
Divestitures | - | - | - | - | - | 131.21 | Upgrade
|
Investment in Securities | 105.86 | 39.68 | 370.87 | -1,308 | -506.43 | -590.65 | Upgrade
|
Other Investing Activities | 78.98 | 41.92 | 43.48 | 60.98 | 29.51 | 24.21 | Upgrade
|
Investing Cash Flow | -17.82 | -127.03 | 68.67 | -1,237 | -658.8 | -511.49 | Upgrade
|
Short-Term Debt Issued | - | - | 30 | - | - | - | Upgrade
|
Total Debt Issued | - | - | 30 | - | - | - | Upgrade
|
Short-Term Debt Repaid | - | - | -30 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -1.95 | -2.17 | -0.8 | - | -70 | Upgrade
|
Total Debt Repaid | -1.52 | -1.95 | -32.17 | -0.8 | - | -70 | Upgrade
|
Net Debt Issued (Repaid) | -1.52 | -1.95 | -2.17 | -0.8 | - | -70 | Upgrade
|
Issuance of Common Stock | - | - | 8.89 | 37.96 | - | - | Upgrade
|
Repurchase of Common Stock | -1.35 | -1.12 | -2.32 | -73.27 | - | - | Upgrade
|
Common Dividends Paid | -836.85 | -800.5 | -733.1 | -313.37 | -157.5 | -147 | Upgrade
|
Other Financing Activities | -13.48 | -13.48 | - | - | -5.88 | - | Upgrade
|
Financing Cash Flow | -853.2 | -817.05 | -728.7 | -349.48 | -163.38 | -217 | Upgrade
|
Net Cash Flow | 100.05 | 91.82 | 361.72 | -669.02 | -69.68 | -87.31 | Upgrade
|
Free Cash Flow | 768.07 | 827.02 | 676.02 | 728.55 | 569.97 | 564.85 | Upgrade
|
Free Cash Flow Growth | -0.21% | 22.34% | -7.21% | 27.82% | 0.91% | 54.81% | Upgrade
|
Free Cash Flow Margin | 18.28% | 18.84% | 17.40% | 25.35% | 23.35% | 23.06% | Upgrade
|
Free Cash Flow Per Share | 1.21 | 1.31 | 1.07 | 1.15 | 0.90 | 0.90 | Upgrade
|
Cash Income Tax Paid | 496.28 | 477.78 | 421.79 | 392.17 | 391.59 | 429.07 | Upgrade
|
Levered Free Cash Flow | 500.52 | 643.32 | 517.63 | 862.86 | 348.06 | 514.57 | Upgrade
|
Unlevered Free Cash Flow | 502.91 | 647.68 | 520.37 | 865.02 | 349.27 | 514.57 | Upgrade
|
Change in Net Working Capital | -15.14 | -205.06 | -341.3 | -617.02 | -88.45 | -164.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.